Theoretical Considerations of the Prigogine-Defay Ratio with Regard to the Glass-Forming Ability of Drugs from Undercooled Melts.

Drug behavior in undercooled melts is highly important for pharmaceutics with regard to amorphous solid dispersions, and therefore, categories were recently introduced that differentiate glass formers (GFs) from other drugs that are nonglass formers (nGFs). The present study is based on the assumption that molecular properties relevant for the so-called Prigogine-Defay (PD) ratio would be indicative of a drug's glass-forming ability. The PD ratio depends in theory on the entropy of fusion and molar volume. Experimental data were gathered from a broad set of pharmaceutical compounds (n = 54) using differential scanning calorimetry. The obtained entropy of fusion and molar volume were indeed found to significantly discriminate GFs from nGFs. In a next step, the entropy of fusion was predicted by different in silico methods. A first group contribution method provided rather unreliable estimates for the entropy of fusion, while an alternative in silico approach seemed more promising for drug categorization. Thus, a significant discrimination model employed molar volume, a so-called effective hydrogen bond number, and effective number of torsional bonds (or torsional units) to categorize GFs and nGFs (p ≤ 0.0000). The results led to new insights into drug vitrification and to practical rules of thumb. The latter may serve as guidance in pharmaceutical profiling and early formulation development with respect to amorphous drug formulations.

[1]  C. Schick,et al.  On the theoretical determination of the Prigogine-Defay ratio in glass transition. , 2012, The Journal of chemical physics.

[2]  Christel A.S. Bergström,et al.  Early drug development predictions of glass-forming ability and physical stability of drugs. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[3]  George Zografi,et al.  Assessing the performance of amorphous solid dispersions. , 2012, Journal of pharmaceutical sciences.

[4]  C. Strachan,et al.  Investigation of properties and recrystallisation behaviour of amorphous indomethacin samples prepared by different methods. , 2011, International journal of pharmaceutics.

[5]  Vesa-Pekka Lehto,et al.  Predicting the formation and stability of amorphous small molecule binary mixtures from computationally determined Flory-Huggins interaction parameter and phase diagram. , 2010, Molecular pharmaceutics.

[6]  C. Angell,et al.  Formation of Glasses from Liquids and Biopolymers , 1995, Science.

[7]  Chandan Bhugra,et al.  Role of thermodynamic, molecular, and kinetic factors in crystallization from the amorphous state. , 2008, Journal of pharmaceutical sciences.

[8]  J. Schmelzer,et al.  Phenomenological theories of glass transition: Classical approaches, new solutions and perspectives , 2008 .

[9]  Edgar Dutra Zanotto,et al.  A test of the Hrubÿ parameter to estimate glass-forming ability , 1997 .

[10]  Christel A. S. Bergström,et al.  Toward in silico prediction of glass-forming ability from molecular structure alone: a screening tool in early drug development. , 2011, Molecular pharmaceutics.

[11]  K. Kawakami,et al.  Modification of physicochemical characteristics of active pharmaceutical ingredients and application of supersaturatable dosage forms for improving bioavailability of poorly absorbed drugs. , 2012, Advanced drug delivery reviews.

[12]  D. Uhlmann A kinetic treatment of glass formation , 1972 .

[13]  D. Turnbull Under what conditions can a glass be formed , 1969 .

[14]  Akash Jain,et al.  Estimation of melting points of organic compounds-II. , 2006, Journal of pharmaceutical sciences.

[15]  L. S. Taylor,et al.  Classification of the Crystallization Behavior of Amorphous Active Pharmaceutical Ingredients in Aqueous Environments , 2013, Pharmaceutical Research.

[16]  D. Cangialosi Dynamics and thermodynamics of polymer glasses , 2013, Journal of physics. Condensed matter : an Institute of Physics journal.

[17]  Jose Manuel Barandiaran,et al.  Continuous cooling approximation for the formation of a glass , 1981 .

[18]  Z. Lu,et al.  Glass formation criterion for various glass-forming systems. , 2003, Physical review letters.

[19]  J. Schmelzer,et al.  Structural order parameters, the Prigogine–Defay ratio and the behavior of the entropy in vitrification , 2009 .

[20]  Bernard Van Eerdenbrugh,et al.  A classification system to assess the crystallization tendency of organic molecules from undercooled melts. , 2010, Journal of pharmaceutical sciences.

[21]  N. Trasi,et al.  Factors influencing crystal growth rates from undercooled liquids of pharmaceutical compounds. , 2014, The journal of physical chemistry. B.

[22]  S. Yalkowsky,et al.  Modified Trouton's Rule for Predicting the Entropy of Boiling , 1996 .

[23]  Bernard Van Eerdenbrugh,et al.  Crystallization tendency of active pharmaceutical ingredients following rapid solvent evaporation--classification and comparison with crystallization tendency from undercooled melts. , 2010, Journal of pharmaceutical sciences.

[24]  S. Yalkowsky,et al.  Estimation of entropy of melting from molecular structure : A non-group contribution method , 1996 .

[25]  Waseem Kaialy,et al.  Computational predictions of glass-forming ability and crystallization tendency of drug molecules. , 2014, Molecular pharmaceutics.

[26]  D. T. Friesen,et al.  Hydroxypropyl methylcellulose acetate succinate-based spray-dried dispersions: an overview. , 2008, Molecular pharmaceutics.

[27]  M. Poulain,et al.  Glass Forming Ability Criterion , 1987 .

[28]  Y. Ran,et al.  Evaluation of Drug Load and Polymer by Using a 96-Well Plate Vacuum Dry System for Amorphous Solid Dispersion Drug Delivery , 2012, AAPS PharmSciTech.

[29]  Emmanuel Scheubel,et al.  Miniaturized screening of polymers for amorphous drug stabilization (SPADS): rapid assessment of solid dispersion systems. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[30]  W. Kauzmann The Nature of the Glassy State and the Behavior of Liquids at Low Temperatures. , 1948 .

[31]  B. Admire,et al.  Estimating the physicochemical properties of polyhalogenated aromatic and aliphatic compounds using UPPER: part 1. Boiling point and melting point. , 2015, Chemosphere.

[32]  J Dressman,et al.  Improving drug solubility for oral delivery using solid dispersions. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[33]  M. Weinberg Glass-forming ability and glass stability in simple systems , 1994 .

[34]  J. Schmelzer,et al.  Kinetic criteria of glass-formation, pressure dependence of the glass-transition temperature, and the Prigogine–Defay ratio , 2015 .

[35]  S. Yalkowsky,et al.  Molecular Symmetry and Related Properties , 1993 .

[36]  Gert Fricker,et al.  Biopharmaceutical classification of poorly soluble drugs with respect to "enabling formulations". , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[37]  K. Joback,et al.  ESTIMATION OF PURE-COMPONENT PROPERTIES FROM GROUP-CONTRIBUTIONS , 1987 .

[38]  A. Hrubý Evaluation of glass-forming tendency by means of DTA , 1972 .

[39]  M. Eusébio,et al.  Glass-forming ability of butanediol isomers , 2010 .

[40]  G. Adam,et al.  On the Temperature Dependence of Cooperative Relaxation Properties in Glass‐Forming Liquids , 1965 .

[41]  Beom-Jin Lee,et al.  Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.